Bridging mice to men

Using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans

David V. Serreze, Marijke Niens, John Kulik, Teresa P. DiLorenzo

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Similar to the vast majority of cases in humans, the development of type 1 diabetes (T1D) in the NOD mouse model is due to T-cell mediated autoimmune destruction of insulin producing pancreatic β cells. Particular major histocompatibility complex (MHC) haplotypes (designated HLA in humans; and H2 in mice) provide the primary genetic risk factor for T1D development. It has long been appreciated that within the MHC, particular unusual class II genes contribute to the development of T1D in both humans and NOD mice by allowing for the development and functional activation of β cell autoreactive CD4 T cells. However, studies in NOD mice have revealed that through interactions with other background susceptibility genes, the quite common class I variants (Kd, Db) characterizing this strain’s H2g7 MHC haplotype aberrantly acquire an ability to support the development of β cell autoreactive CD8 T cell responses also essential to T1D development. Similarly, recent studies indicate that in the proper genetic context some quite common HLA class I variants also aberrantly contribute to T1D development in humans. This review focuses on how “humanized” HLA transgenic NOD mice can be created and used to identify class I dependent β cell autoreactive CD8 T cell populations of clinical relevance to T1D development. There is also discussion on how HLA transgenic NOD mice can be used to develop protocols that may ultimately be useful for the prevention of T1D in humans by attenuating autoreactive CD8 T cell responses against pancreatic β cells.

Original languageEnglish (US)
Pages (from-to)137-151
Number of pages15
JournalMethods in Molecular Biology
Volume1438
DOIs
StatePublished - May 1 2016

Fingerprint

Type 1 Diabetes Mellitus
Transgenic Mice
Inbred NOD Mouse
T-Lymphocytes
Major Histocompatibility Complex
Human Development
Haplotypes
MHC Class II Genes
Aptitude
Insulin
Population
Genes

Keywords

  • Autoimmunity
  • HLA transgenics
  • T cells
  • Type 1 diabetes (T1D)
  • “Humanized” NOD mice

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Bridging mice to men : Using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans. / Serreze, David V.; Niens, Marijke; Kulik, John; DiLorenzo, Teresa P.

In: Methods in Molecular Biology, Vol. 1438, 01.05.2016, p. 137-151.

Research output: Contribution to journalReview article

@article{cc059adbceba4ce2b42b321eb558b643,
title = "Bridging mice to men: Using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans",
abstract = "Similar to the vast majority of cases in humans, the development of type 1 diabetes (T1D) in the NOD mouse model is due to T-cell mediated autoimmune destruction of insulin producing pancreatic β cells. Particular major histocompatibility complex (MHC) haplotypes (designated HLA in humans; and H2 in mice) provide the primary genetic risk factor for T1D development. It has long been appreciated that within the MHC, particular unusual class II genes contribute to the development of T1D in both humans and NOD mice by allowing for the development and functional activation of β cell autoreactive CD4 T cells. However, studies in NOD mice have revealed that through interactions with other background susceptibility genes, the quite common class I variants (Kd, Db) characterizing this strain’s H2g7 MHC haplotype aberrantly acquire an ability to support the development of β cell autoreactive CD8 T cell responses also essential to T1D development. Similarly, recent studies indicate that in the proper genetic context some quite common HLA class I variants also aberrantly contribute to T1D development in humans. This review focuses on how “humanized” HLA transgenic NOD mice can be created and used to identify class I dependent β cell autoreactive CD8 T cell populations of clinical relevance to T1D development. There is also discussion on how HLA transgenic NOD mice can be used to develop protocols that may ultimately be useful for the prevention of T1D in humans by attenuating autoreactive CD8 T cell responses against pancreatic β cells.",
keywords = "Autoimmunity, HLA transgenics, T cells, Type 1 diabetes (T1D), “Humanized” NOD mice",
author = "Serreze, {David V.} and Marijke Niens and John Kulik and DiLorenzo, {Teresa P.}",
year = "2016",
month = "5",
day = "1",
doi = "10.1007/978-1-4939-3661-8_9",
language = "English (US)",
volume = "1438",
pages = "137--151",
journal = "Methods in Molecular Biology",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Bridging mice to men

T2 - Using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans

AU - Serreze, David V.

AU - Niens, Marijke

AU - Kulik, John

AU - DiLorenzo, Teresa P.

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Similar to the vast majority of cases in humans, the development of type 1 diabetes (T1D) in the NOD mouse model is due to T-cell mediated autoimmune destruction of insulin producing pancreatic β cells. Particular major histocompatibility complex (MHC) haplotypes (designated HLA in humans; and H2 in mice) provide the primary genetic risk factor for T1D development. It has long been appreciated that within the MHC, particular unusual class II genes contribute to the development of T1D in both humans and NOD mice by allowing for the development and functional activation of β cell autoreactive CD4 T cells. However, studies in NOD mice have revealed that through interactions with other background susceptibility genes, the quite common class I variants (Kd, Db) characterizing this strain’s H2g7 MHC haplotype aberrantly acquire an ability to support the development of β cell autoreactive CD8 T cell responses also essential to T1D development. Similarly, recent studies indicate that in the proper genetic context some quite common HLA class I variants also aberrantly contribute to T1D development in humans. This review focuses on how “humanized” HLA transgenic NOD mice can be created and used to identify class I dependent β cell autoreactive CD8 T cell populations of clinical relevance to T1D development. There is also discussion on how HLA transgenic NOD mice can be used to develop protocols that may ultimately be useful for the prevention of T1D in humans by attenuating autoreactive CD8 T cell responses against pancreatic β cells.

AB - Similar to the vast majority of cases in humans, the development of type 1 diabetes (T1D) in the NOD mouse model is due to T-cell mediated autoimmune destruction of insulin producing pancreatic β cells. Particular major histocompatibility complex (MHC) haplotypes (designated HLA in humans; and H2 in mice) provide the primary genetic risk factor for T1D development. It has long been appreciated that within the MHC, particular unusual class II genes contribute to the development of T1D in both humans and NOD mice by allowing for the development and functional activation of β cell autoreactive CD4 T cells. However, studies in NOD mice have revealed that through interactions with other background susceptibility genes, the quite common class I variants (Kd, Db) characterizing this strain’s H2g7 MHC haplotype aberrantly acquire an ability to support the development of β cell autoreactive CD8 T cell responses also essential to T1D development. Similarly, recent studies indicate that in the proper genetic context some quite common HLA class I variants also aberrantly contribute to T1D development in humans. This review focuses on how “humanized” HLA transgenic NOD mice can be created and used to identify class I dependent β cell autoreactive CD8 T cell populations of clinical relevance to T1D development. There is also discussion on how HLA transgenic NOD mice can be used to develop protocols that may ultimately be useful for the prevention of T1D in humans by attenuating autoreactive CD8 T cell responses against pancreatic β cells.

KW - Autoimmunity

KW - HLA transgenics

KW - T cells

KW - Type 1 diabetes (T1D)

KW - “Humanized” NOD mice

UR - http://www.scopus.com/inward/record.url?scp=84966397560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966397560&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-3661-8_9

DO - 10.1007/978-1-4939-3661-8_9

M3 - Review article

VL - 1438

SP - 137

EP - 151

JO - Methods in Molecular Biology

JF - Methods in Molecular Biology

SN - 1064-3745

ER -